Fractyl Labs, working to cure diabetes, moves to Lexington

Published for The Lexington Minuteman Aug. 27.

With Lexington’s Hartwell Avenue corridor a haven for technology companies, Harith Rajagopalanit decided it only made sense for him to move his biomedical company, Fractyl Laboratories, there.

“There’s a really vibrant life sciences sector in Lexington, and Hartwell Avenue has a number of different companies,” said Rajagopalan, co-founder and chief executive officer of Fractyl.

Fractyl Laboratories, formerly a Waltham-based company, is working to develop a cure to hyperglycemia or type-2 diabetes. The disease causes the body to not process blood sugars correctly, causing a buildup of sugars in the blood.

Fractyl’s research is focused around a catheter which burns tissue in a specific location of the small intestine, which Rajagopalan believes will prove to be a cure for the disease.

For the rest of this article, click here

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s